Panacea Life Sciences Holdings, Inc. (PLSH)
OTCMKTS · Delayed Price · Currency is USD
0.0324
0.00 (0.00%)
Jul 31, 2025, 8:00 PM EDT

PLSH Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Mar '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
2.762.381.632.069.022.2
Revenue Growth (YoY)
50.38%46.59%-21.01%-77.16%310.19%-
Cost of Revenue
6.636.476.196.4811.473.88
Gross Profit
-3.87-4.09-4.56-4.42-2.45-1.68
Selling, General & Admin
1.451.461.091.522.810.99
Operating Expenses
1.451.461.091.522.810.99
Operating Income
-5.31-5.55-5.65-5.94-5.26-2.67
Interest Expense
-1.61-1.56-2.05-1.11-1.51-0.43
Other Non Operating Income (Expenses)
0.150.180.260.240.250.66
EBT Excluding Unusual Items
-6.76-6.92-7.44-6.81-6.52-2.45
Gain (Loss) on Sale of Investments
-0.91-1.09-2.641.171.430.13
Gain (Loss) on Sale of Assets
----0.3-0.14-0.49
Other Unusual Items
-00.941.15--
Pretax Income
-7.67-8.02-9.14-4.78-5.23-2.81
Net Income
-7.67-8.02-9.14-4.78-5.23-2.81
Net Income to Common
-7.67-8.02-9.14-4.78-5.23-2.81
Shares Outstanding (Basic)
171715181718
Shares Outstanding (Diluted)
171715181718
Shares Change (YoY)
18.33%11.88%-16.60%5.35%-4.90%-
EPS (Basic)
-0.45-0.48-0.62-0.27-0.31-0.16
EPS (Diluted)
-0.45-0.48-0.62-0.27-0.31-0.16
Free Cash Flow
-1.62-1.59-2.64-4.09-10.85-10.87
Free Cash Flow Per Share
-0.10-0.10-0.18-0.23-0.64-0.61
Gross Margin
-139.86%-171.48%-280.20%-214.53%-27.19%-76.56%
Operating Margin
-192.25%-232.55%-347.41%-288.26%-58.31%-121.42%
Profit Margin
-277.51%-336.08%-561.94%-232.20%-58.02%-127.88%
Free Cash Flow Margin
-58.71%-66.66%-162.47%-198.34%-120.28%-494.42%
EBITDA
-3.64-3.83-3.92-4.2-3.57-1.87
EBITDA Margin
-131.68%-160.72%-241.01%-203.92%-39.54%-85.28%
D&A For EBITDA
1.671.711.731.741.690.79
EBIT
-5.31-5.55-5.65-5.94-5.26-2.67
EBIT Margin
-192.25%-232.55%--288.26%-58.31%-121.42%
Advertising Expenses
-0.020.210.381.50.25
Source: S&P Global Market Intelligence. Standard template. Financial Sources.